The Clorox Company (FRA:CXX)

Intra-Cellular Therapies Revenue

In the fiscal year ending June 30, 2025, The Clorox Company had annual revenue of $7.10B USD with 0.16% growth. The Clorox Company had revenue of $1.99B in the quarter ending June 30, 2025, with 4.47% growth.

• Revenue: $7.10B
• Revenue Growth: +0.16%
• P/S Ratio: 2.24
• Revenue / Employee: $888.00K
• Employees: 8,000
• Market Cap: 13.53B

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	7.10B	11.00M	0.16%
Jun 30, 2024	7.09B	-296.00M	-4.01%
Jun 30, 2023	7.39B	282.00M	3.97%
Jun 30, 2022	7.11B	-234.00M	-3.19%
Jun 30, 2021	7.34B	620.00M	9.22%